Methyl Nicotinate

Methyl Nicotinate

SCHEMBL3086138

CO.COC(=O)c1cccnc1

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.96
KMT2A Q03164 6/20 0.65
HSD17B10 Q99714 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
APP P05067 1/20 0.57
GAA P10253 1/20 0.57
HCAR3 P49019 1/20 0.57
HCAR2 Q8TDS4 1/20 0.57
HDAC1 Q13547 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
TSHR P16473 1/20 0.55
CYP19A1 P11511 1/20 0.55
CYP11B1 P15538 1/20 0.55
CYP11B2 P19099 1/20 0.55
F7 P08709 1/20 0.55
F3 P13726 1/20 0.55
SARM1 Q6SZW1 1/20 0.55
SIRT2 Q8IXJ6 1/20 0.55
SIRT6 Q8N6T7 1/20 0.55
SIRT1 Q96EB6 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Nicotinate SCHEMBL820747 0.98 ALDH1A1 (1.00) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL24566 0.98 ALDH1A1 (1.00) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL29386553 0.98 ALDH1A1 (1.00) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL28247726 0.96 ALDH1A1 (0.89) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL28370871 0.96 ALDH1A1 (0.96) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL30668199 0.96 ALDH1A1 (0.96) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL11491005 0.96 ALDH1A1 (0.96) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL30791985 0.96 ALDH1A1 (0.96) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL30779127 0.96 ALDH1A1 (0.96) ALDH1A1KMT2AHSD17B10L3MBTL1APP
Methyl Nicotinate SCHEMBL30541951 0.96 ALDH1A1 (0.96) ALDH1A1KMT2AHSD17B10L3MBTL1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110305143-A A kind of furans [2,3-c] and pyridine derivate and its preparation method and application 济南新科医药科技有限公司 2019-10-08 CN disclosed
US-20100227896-A1 USE OF VITAMIN PP COMPOUNDS ASTELLAS DEUTSCHLAND GMBH (DE) 2010-09-09 US disclosed
EP-1079832-B1 USE OF VITAMIN PP COMPOUNDS KLINGE CO CHEM PHARM FAB (DE) 2005-11-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100227896-A1 USE OF VITAMIN PP COMPOUNDS PNPO, NAMPT, NAPRT ALDH1A1 1385/4885KMT2A 2179/4885HSD17B10 3302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.